{
    "organizations": [],
    "uuid": "b901ac0ff6835da2105cbe73db40c81c9b45b706",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hybrigenics-broad-spectrum-inhibit/brief-hybrigenics-broad-spectrum-inhibitor-of-ubiquitin-specific-proteases-shows-antiviral-activity-against-human-adenoviruses-idUSFWN1R810G",
    "ord_in_thread": 0,
    "title": "BRIEF-Hybrigenics: Broad-Spectrum Inhibitor Of Ubiquitin-Specific Proteases Shows Antiviral Activity Against Human Adenoviruses",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - HYBRIGENICS SA:\n* BROAD-SPECTRUM INHIBITOR OF UBIQUITIN-SPECIFIC PROTEASES SHOWS ANTIVIRAL ACTIVITY AGAINST HUMAN ADENOVIRUSES\n* ON 11 OUT OF 13 VIRAL TYPES TESTED, HBX 47,939 WAS SHOWN TO INHIBIT VIRAL REPLICATION IN INFECTED CELLS\n* HBX 47,939 WAS SHOWN TO DECREASE PRODUCTION OF NEW VIRIONS RELEASED IN CULTURE MEDIUM Source text: bit.ly/2ITlGJG Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-27T00:57:00.000+03:00",
    "crawled": "2018-03-27T11:44:16.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "hybrigenics",
        "sa",
        "inhibitor",
        "protease",
        "show",
        "antiviral",
        "activity",
        "human",
        "adenovirus",
        "viral",
        "type",
        "tested",
        "hbx",
        "shown",
        "inhibit",
        "viral",
        "replication",
        "infected",
        "cell",
        "hbx",
        "shown",
        "decrease",
        "production",
        "new",
        "virion",
        "released",
        "culture",
        "medium",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}